Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
Amazon is hiring more healthcare leaders — and expanding its drug and medical supply distribution — in what may be the company's first step into the pharmacy business, reports CNBC.
Here are the four latest drugs or medical devices approved by the Food and Drug Administration in the past week.
An estimated 28 million Americans saw the price of their prescription medication rise in the past 12 months, according to a recent Consumer Reports survey.
"General Hospital," the longest-running soap opera in the U.S., partnered with pharma company Incyte to raise awareness about an extremely rare bone marrow cancer. However, the partnership raises ethical questions, according to an article in JAMA — Incyte owns the…
Just five retail pharmacy chains have more than 1,000 stores scattered throughout the U.S., according to data from SK&A's April 2017 "National Pharmacy Market Summary" report.
Decreasing reimbursements amid rising operational costs can threaten a healthcare organization's bottom line.
Reducing fee structures associated with supply chain expenses is an often overlooked, yet effective strategy to lowering costs, according to Tom Fox, a managing director at healthcare consulting firm Nova Strategies.
Vertex Pharmaceuticals on Wednesday received expanded approval from the Food and Drug Administration for its cystic fibrosis drug, Kalydeco.
The Food and Drug Administration on Wednesday approved MindMaze's upper-limb rehabilitation platform, MindMotion Pro.
Johnson & Johnson on Wednesday said it's developing at least 10 new drugs, each of which holds potential worldwide sales of $1 billion, reports USA Today.